# Stephen C. Yang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stephen-c-yang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,886 |
| Field | Lung Cancer Diagnosis and Treatment |
| h-index | 54 |
| i10-index | 117 |
| Last Known Institution | Johns Hopkins University |
| OpenAlex ID | https://openalex.org/A5019578689 |
| ORCID iD | https://orcid.org/0000-0003-2188-3407 |
| Works | 229 |

## Researcher papers

Showing 12 of 13.

- [Neoadjuvant PD-1 Blockade in Resectable Lung Cancer](https://scholariq.org/papers/neoadjuvant-pd-1-blockade-in-resectable-lung-cancer/)
- [Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/non-small-cell-lung-cancer-version-3-2022-nccn-clinical-practice-guidelines-in/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2021/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-1-2020/)
- [Non–Small Cell Lung Cancer, Version 4.2024](https://scholariq.org/papers/non-small-cell-lung-cancer-version-4-2024/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-4-2016/)
- [Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)](https://scholariq.org/papers/pathologic-features-of-response-to-neoadjuvant-anti-pd-1-in-resected-non-small/)
- [NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2023/)
- [Non–Small Cell Lung Cancer, Version 6.2015](https://scholariq.org/papers/non-small-cell-lung-cancer-version-6-2015/)
- [Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung](https://scholariq.org/papers/cigarette-smoking-is-strongly-associated-with-mutation-of-the-k-ras-gene-in/)
- [Epigenetic therapy inhibits metastases by disrupting premetastatic niches](https://scholariq.org/papers/epigenetic-therapy-inhibits-metastases-by-disrupting-premetastatic-niches/)
- [Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer](https://scholariq.org/papers/initial-results-of-pulmonary-resection-after-neoadjuvant-nivolumab-in-patients/)

## Researcher topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Diversity and Career in Medicine](https://scholariq.org/topics/diversity-and-career-in-medicine/)

## Researcher university

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.